XXXX18日本视频XXXXX|精品综合久久中文字幕|又大又粗的久久久精品少妇AV|99久久久无码欧洲精品免费|

Investment Strategy Investment Case Related news Financing

Successful conclusion | Guoqian Venture Capital Medical Devices Special Session Closed Roadshow 2019

Author: ComeFrom: Date:2019/11/29 8:42:52 Hits:1354

Guoqian Venture Capital's fourth quarter of 2019 medical device special closed-door roadshow was successfully held on November 28, 2019 at Taihu Jingu Roadshow Center in Suzhou High-tech Zone. The event was organized by Guoqian Venture Capital Management (Suzhou) Co., Ltd., undertaken by Shenzhen Zhongbo Enterprise Service Co., Ltd. (Chuangchenghui Platform), and co-organized by Taihu Jingu (Suzhou) Development Co., Ltd. Zhang Xu, Chairman of Guoqian Venture Capital, Wang Minghao, Vice President and General Manager of Angel Investment of Su Gaoxin Venture Capital Group, Chen Miao, Partner of Huatai Zijin Investment, Bao Yanghuan, Investment Partner of Mint Angel Fund, Su Gaoxin Venture Capital Guests such as General Manager Miao Lu and Guo Hao Venture Partners Chen Hao attended the event. The organizer has selected many projects in the country that actively participated in the road show, and finally selected 11 projects to participate in this live road show.


At the beginning of the conference, Dr. Zhang Xu, chairman of Guoqian Venture Capital Management (Suzhou) Co., Ltd., gave an impromptu speech, and sincerely welcomed the guests and entrepreneurs who participated in the roadshow. Dr. Zhang Xu shared the wonderful entrepreneurial experience: to be happy and confident to start a business, only in this way can we overcome the hardships and difficulties of the entrepreneurial road; to be kind to partners and employees, they are valuable assets for entrepreneurs; companies must have their own Core competitiveness, such as possessing breakthrough and innovative technological advantages. Dr. Zhang Xu shared the wonderful history of the founding of Shishi Biology on the December 5 this year, and pointed out that the entrepreneur must be one of the most dreamy people and a real dream chaser. Guo Qian's dream is to gather more than 100 mid- to high-end start-ups in the medical device field in Suzhou High-tech Zone in 10 years. Dr. Zhang Xu's speech strengthened the confidence of the entrepreneurs, aroused the resonance of the audience, and won warm applause from the scene.


1

Roadshow session

During the roadshow session, roadshow guests appeared one after another. The 10-minute roadshow + 10 minutes of free Q & A for each project were wonderful.


Xu Feng: Artificial intelligence solutions for children with genetic rare diseases


Li Yan: R & D and application of 3D oral biomaterials


Hu Qingliu: absorbable bioactive bone inducing material


Song Xiaoyun: MAC ROBOT intelligent mobility robot


Zhang Feng: Guangrou Technology Beauty Health


Zhang Lei: Gaorong Technology Medical AI Project


Zhou Guoqing: Orthopedic surgery robot


Liu Ping: radiofrequency treatment of tumor


Yang Fulei: Household micro-hyperbaric oxygen cabin


Tang Ning: AI optometry optician


Liu Nian: AI intelligent auxiliary equipment for endoscope

At the road show center, the judges listened carefully to the road show project, "pulse" on site, and gave professional and accurate comments on the project.


2

Free communication


After the road show, it is a free communication and project docking link. Dr. Hao Chen, a partner of Guoqian Venture Capital, has many years of experience and professional background as a judge of roadshow contests in various regions. In addition to the reviews, he also conducted further in-depth exchanges with some roadshow guests on the spot and proposed targeted and practical Suggestions. Through the introduction of the organizer, the guests of the road show had a preliminary understanding of the entrepreneurial environment and industrial development policies of the medical device in Suzhou High-tech Zone. At the event site, the investor and some road show project parties reached a preliminary cooperation intention.

3

Highlights

1. Strong fund support: access to venture capital opportunities of Suzhou Guoqian Fund, Suzhou High-tech Zone Industrial Fund, Mint Angel Fund and Nanjing Huatai Zijin;

2. Strong expert team: experts of the “National Thousand Talents Program” and investors ’professional judgment and post-investment value-added services;

3. Industry incubator: Connect to the value-added services of the "Guoqian Medical Technology Innovation Research Institute" model;

4. Geographical advantages: Suzhou High-tech Zone is an area in Jiangsu Province that focuses on supporting the development of the medical device industry in the "One District, One Industry" strategic layout.

Guoqian Venture Capital

Guoqian Venture Capital was jointly established by Dr. Zhang Xu and other six national thousand-person plan experts with successful entrepreneurship or industrial experience in various segments of medical devices, and Suzhou Institute of Medical Engineering, Chinese Academy of Sciences and other shareholders. A professional and market-oriented venture capital institution focusing on equity investment in early-stage innovation and entrepreneurship projects in the fields of medical devices, in vitro diagnostic reagents and biotechnology. Based on the business philosophy of “achieving the dreams of others”, Guoqian Venture Capital seeks for high-end scientific and technological talents centered on experts from the National Thousand Talents Program in the transformation of scientific and technological achievements, the introduction of technological projects, the evaluation of innovative and entrepreneurial projects, and the landing of innovative and entrepreneurial projects Quality investment target, while providing value-added services. At present, it has invested in Aishi Medical (Ophthalmology AI), Ruiqian Technology (Pathology AI), Xinqing Medical (in vitro artificial heart), Spectrum Life (mass spectrometry detection), Huanuo Biology (hemostatic material), Qingpu Technology (small Mass spectrometry), Guoke Junhao (POCT), Angkai Life (methylation detection reagents), Alpha Bio (monoclonal antibody protein) and many other start-up high-quality enterprises.

Previous:Successful conclusion / Guoqian Medical First Private Council
Next:Guoqian Venture Capital helped Angkai Life get the first round of over ten million financing